{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:24:55Z","timestamp":1791199495285,"version":"4.2.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["320030_130243"],"award-info":[{"award-number":["320030_130243"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jhep.2014.06.035","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T01:17:41Z","timestamp":1414977461000},"page":"S14-S25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":274,"special_numbering":"S","title":["Innate and adaptive immune responses in HCV infections"],"prefix":"10.1016","volume":"61","author":[{"given":"Markus H.","family":"Heim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Thimme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.06.035_b0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","article-title":"The global burden of hepatitis C","volume":"29","author":"Lavanchy","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.06.035_b0010","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jhep.2014.06.035_b0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2008.07.005","article-title":"Acute hepatitis C: current status and remaining challenges","volume":"49","author":"Santantonio","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0025","doi-asserted-by":"crossref","first-page":"e1261","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0030","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defence","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2014.06.035_b0035","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2014.06.035_b0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2014.06.035_b0045","doi-asserted-by":"crossref","first-page":"15315","DOI":"10.1074\/jbc.R700007200","article-title":"Function of RIG-I-like receptors in antiviral innate immunity","volume":"282","author":"Yoneyama","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.06.035_b0050","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ni1087","article-title":"The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses","volume":"5","author":"Yoneyama","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2014.06.035_b0055","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0060","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0065","doi-asserted-by":"crossref","first-page":"e776","DOI":"10.1053\/j.gastro.2012.05.044","article-title":"Interferon-gamma-stimulated genes, but not USP18, are expressed in livers of patients with acute hepatitis C","volume":"143","author":"Dill","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0070","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signalling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0075","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defence","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.06.035_b0080","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2014.06.035_b0085","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2014.06.035_b0090","doi-asserted-by":"crossref","first-page":"e1000151","DOI":"10.1371\/journal.ppat.1000151","article-title":"Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses","volume":"4","author":"Mordstein","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2014.06.035_b0095","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1128\/JVI.00272-10","article-title":"Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections","volume":"84","author":"Mordstein","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0100","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2014.06.035_b0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1189\/jlb.0204117","article-title":"The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain","volume":"76","author":"Donnelly","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jhep.2014.06.035_b0110","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.20131557","article-title":"IFN-lambda receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-lambda3 genotype and with nonresponsiveness to IFN-alpha therapies","volume":"211","author":"Duong","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0115","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","article-title":"STATs and gene regulation","volume":"277","author":"Darnell","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.06.035_b0120","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7871432","article-title":"Contribution of STAT SH2 groups to specific interferon signalling by the Jak-STAT pathway","volume":"267","author":"Heim","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.06.035_b0125","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","article-title":"Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signalling proteins","volume":"264","author":"Darnell","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.06.035_b0130","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1128\/JVI.02438-06","article-title":"Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signalling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases","volume":"81","author":"Zhou","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0135","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1634\/stemcells.19-5-378","article-title":"SOCS proteins: negative regulators of cytokine signalling","volume":"19","author":"Krebs","year":"2001","journal-title":"Stem Cells"},{"key":"10.1016\/j.jhep.2014.06.035_b0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ni1287","article-title":"Suppressor of cytokine signalling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity","volume":"7","author":"Fenner","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2014.06.035_b0145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","article-title":"SOCS1 is a critical inhibitor of interferon gamma signalling and prevents the potentially fatal neonatal actions of this cytokine","volume":"98","author":"Alexander","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2014.06.035_b0150","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of interferon signalling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.jhep.2014.06.035_b0155","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1128\/MCB.00224-09","article-title":"Alpha interferon induces long-lasting refractoriness of JAK-STAT signalling in the mouse liver through induction of USP18\/UBP43","volume":"29","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2014.06.035_b0160","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.24189","article-title":"Interferon-beta and interferon-lambda signalling is not affected by interferon-induced refractoriness to interferon-alpha in vivo","volume":"53","author":"Makowska","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0165","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0170","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0175","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0180","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0185","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.gastro.2005.01.049","article-title":"Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production","volume":"128","author":"Dahari","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0190","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0195","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-lambda and interferon-stimulated genes in primary liver cultures","volume":"54","author":"Marukian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0200","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0205","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/hep.25897","article-title":"IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection","volume":"56","author":"Park","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0210","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1002301107","article-title":"Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection","volume":"107","author":"Takahashi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0215","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon-lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0220","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1053\/j.gastro.2012.04.018","article-title":"Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response","volume":"143","author":"Bauhofer","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0225","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.26115","article-title":"Natural killer cells in liver disease","volume":"57","author":"Tian","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0230","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells","volume":"19","author":"Rehermann","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0235","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1172\/JCI67714","article-title":"Emerging concepts in immunity to hepatitis C virus infection","volume":"123","author":"Rosen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0240","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.06.035_b0245","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2014.04.020","article-title":"KIR2DL3NKG2A natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs","volume":"61","author":"Thoens","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0250","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1053\/j.gastro.2010.01.006","article-title":"Activation of natural killer cells during acute infection with hepatitis C virus","volume":"138","author":"Amadei","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0255","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/j.gastro.2011.08.025","article-title":"A view to natural killer cells in hepatitis C","volume":"141","author":"Shoukry","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0260","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2010.05.013","article-title":"Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses","volume":"53","author":"Pelletier","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0265","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jhep.2011.01.005","article-title":"NK cells in acute hepatitis C","volume":"55","author":"Nattermann","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0270","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/hep.26353","article-title":"Innate immune responses in hepatitis C virus exposed healthcare workers who do not develop acute infection","volume":"58","author":"Werner","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0275","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/j.1574-6976.2011.00319.x","article-title":"Failure of innate and adaptive immune responses in controlling hepatitis C virus infection","volume":"36","author":"Thimme","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.jhep.2014.06.035_b0280","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1053\/j.gastro.2011.05.006","article-title":"Delayed induction, not impaired recruitment, of specific CD8(+) T cells causes the late onset of acute hepatitis C","volume":"141","author":"Shin","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0285","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","article-title":"T cell responses in hepatitis C: the good, the bad and the unconventional","volume":"61","author":"Klenerman","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.035_b0290","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0295","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0300","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2014.06.035_b0305","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1128\/JVI.71.8.6011-6019.1997","article-title":"Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection","volume":"71","author":"Diepolder","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0310","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.191.9.1499","article-title":"Analysis of successful immune responses in persons infected with hepatitis C virus","volume":"191","author":"Lechner","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0315","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI118842","article-title":"Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response","volume":"98","author":"Missale","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0320","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0325","first-page":"243","article-title":"Adaptive immune responses in hepatitis C virus infection","volume":"369","author":"Neumann-Haefelin","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jhep.2014.06.035_b0330","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0335","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.06.035_b0340","doi-asserted-by":"crossref","first-page":"e1003422","DOI":"10.1371\/journal.ppat.1003422","article-title":"Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C","volume":"9","author":"Kared","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2014.06.035_b0345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhep.2012.02.030","article-title":"Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential","volume":"57","author":"Jo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0350","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep.26770","article-title":"Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver","volume":"59","author":"Wieland","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0355","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2010.11.039","article-title":"Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C","volume":"140","author":"Dill","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0360","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0365","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0370","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2014.06.035_b0375","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0380","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.23426","article-title":"Cleavage of mitochondrial antiviral signalling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system","volume":"51","author":"Bellecave","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0385","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0390","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/gut.2007.128611","article-title":"Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C","volume":"57","author":"Asselah","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.035_b0395","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","article-title":"Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation","volume":"6","author":"Garaigorta","year":"2009","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jhep.2014.06.035_b0400","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: identifying molecular pathways for treatment response","volume":"46","author":"Feld","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0405","doi-asserted-by":"crossref","first-page":"13779","DOI":"10.1128\/JVI.78.24.13779-13792.2004","article-title":"Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees","volume":"78","author":"Bigger","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0415","doi-asserted-by":"crossref","first-page":"e84026","DOI":"10.1371\/journal.pone.0084026","article-title":"Interferon-lambda4 (IFNL4) transcript expression in human liver tissue samples","volume":"8","author":"Amanzada","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.06.035_b0420","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.06.035_b0425","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0430","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.06.035_b0435","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2014.06.035_b0440","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2014.06.035_b0445","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-deltag allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2014.06.035_b0450","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.26788","article-title":"Hepatic interferon-stimulated genes are differentially regulated in the liver of chronic hepatitis C patients with different interleukin-28B genotypes","volume":"59","author":"Honda","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0455","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jvh.12154","article-title":"Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant","volume":"21","author":"Konishi","year":"2014","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.06.035_b0460","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nature04226","article-title":"A haplotype map of the human genome","volume":"437","author":"HapMapConsortium","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.06.035_b0465","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2005.076463","article-title":"Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C","volume":"55","author":"Nattermann","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.035_b0470","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2362.2010.02332.x","article-title":"Natural killer cells in viral hepatitis: facts and controversies","volume":"40","author":"Mondelli","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0475","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.24628","article-title":"Early changes in interferon signalling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients","volume":"55","author":"Edlich","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0480","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jhep.2010.03.018","article-title":"Altered interferon-alpha-signalling in natural killer cells from patients with chronic hepatitis C virus infection","volume":"53","author":"Miyagi","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0485","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","author":"Lunemann","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2014.06.035_b0490","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.4049\/jimmunol.1300164","article-title":"Hepatitis C virus-infected cells downregulate NKp30 and inhibit ex vivo NK cell functions","volume":"191","author":"Holder","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2014.06.035_b0495","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1053\/j.gastro.2009.08.066","article-title":"Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner","volume":"138","author":"Ahlenstiel","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0500","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0505","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1053\/j.gastro.2010.01.051","article-title":"Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection","volume":"138","author":"Stegmann","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0510","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/hep.25804","article-title":"Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis","volume":"56","author":"Kramer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0515","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2013.04.022","article-title":"IFN-gamma production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells","volume":"59","author":"Zhang","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0520","doi-asserted-by":"crossref","first-page":"e1001184","DOI":"10.1371\/journal.ppat.1001184","article-title":"Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines","volume":"6","author":"Sene","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2014.06.035_b0525","doi-asserted-by":"crossref","first-page":"12557","DOI":"10.1128\/JVI.00838-11","article-title":"Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells","volume":"85","author":"Yoon","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0530","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.22624","article-title":"Natural killer cell function is intact after direct exposure to infectious hepatitis C virions","volume":"49","author":"Yoon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0535","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/JVI.02988-13","article-title":"Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis","volume":"88","author":"Kim","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0540","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.24556","article-title":"Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C","volume":"54","author":"Golden-Mason","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0545","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/gutjnl-2013-304472","article-title":"The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon alpha treatment","volume":"63","author":"Pembroke","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.035_b0550","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/gutjnl-2013-305087","article-title":"NKp46+ expression on NK cells as a biomarker for liver pathology and IFN-responsiveness in HCV infection","volume":"63","author":"Thimme","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.035_b0555","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2013.03.003","article-title":"Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection","volume":"59","author":"Oliviero","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0560","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2011.06.069","article-title":"Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C","volume":"141","author":"Ahlenstiel","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0565","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0570","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1128\/JVI.00459-07","article-title":"Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization","volume":"81","author":"Falkowska","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0575","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1128\/JVI.00127-07","article-title":"The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein","volume":"81","author":"Helle","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0580","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0585","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"Brimacombe","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0590","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI119778","article-title":"Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus","volume":"100","author":"Chang","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0595","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1073\/pnas.92.7.2755","article-title":"Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant","volume":"92","author":"Weiner","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0600","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.4049\/jimmunol.151.8.4189","article-title":"Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C","volume":"151","author":"Erickson","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2014.06.035_b0605","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/hep.20749","article-title":"Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C","volume":"42","author":"Cox","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0610","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20042284","article-title":"Immune evasion vs. recovery after acute hepatitis C virus infection from a shared source","volume":"201","author":"Tester","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0615","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20041006","article-title":"CD8 epitope escape and reversion in acute HCV infection","volume":"200","author":"Timm","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0620","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/nm.3351","article-title":"Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses","volume":"19","author":"Honegger","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2014.06.035_b0625","first-page":"376","article-title":"Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response","volume":"119","author":"Dazert","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0630","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/gut.2010.228403","article-title":"Molecular footprints reveal the impact of the protective HLA-A\u221703 allele in hepatitis C virus infection","volume":"60","author":"Fitzmaurice","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.035_b0635","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/hep.23319","article-title":"Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection","volume":"51","author":"Fuller","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0640","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus vs. innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0645","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0650","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection","volume":"45","author":"Penna","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0655","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0660","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1128\/JVI.00409-07","article-title":"Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction","volume":"81","author":"Golden-Mason","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0665","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1128\/JVI.01075-08","article-title":"Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection","volume":"82","author":"Radziewicz","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0670","doi-asserted-by":"crossref","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2014.06.035_b0675","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","article-title":"Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity","volume":"120","author":"McMahan","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0680","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2013.10.022","article-title":"Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors","volume":"146","author":"Kroy","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.06.035_b0685","doi-asserted-by":"crossref","first-page":"e1002045","DOI":"10.1371\/journal.ppat.1002045","article-title":"Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells","volume":"7","author":"Schlaphoff","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2014.06.035_b0690","doi-asserted-by":"crossref","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160, and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jhep.2014.06.035_b0695","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1073\/pnas.1312772110","article-title":"Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)","volume":"110","author":"Fuller","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.06.035_b0700","doi-asserted-by":"crossref","first-page":"e63818","DOI":"10.1371\/journal.pone.0063818","article-title":"A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection","volume":"8","author":"Gardiner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.06.035_b0705","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JVI.02474-07","article-title":"High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome","volume":"82","author":"Kasprowicz","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0710","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1128\/JVI.03122-12","article-title":"The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection","volume":"87","author":"Shin","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0715","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/hep.20669","article-title":"Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection","volume":"41","author":"Semmo","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0720","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","article-title":"T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection","volume":"79","author":"Boettler","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0725","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/hep.20454","article-title":"An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection","volume":"40","author":"Cabrera","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0730","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1128\/JVI.79.12.7852-7859.2005","article-title":"Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection","volume":"79","author":"Rushbrook","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0735","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2007.03.023","article-title":"Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection","volume":"47","author":"Ward","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0740","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI36604","article-title":"PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV","volume":"119","author":"Franceschini","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0745","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1172\/JCI200420515","article-title":"Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection","volume":"113","author":"Accapezzato","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.06.035_b0750","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/hep.21438","article-title":"Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection","volume":"44","author":"Abel","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.06.035_b0755","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.1128\/JVI.01083-08","article-title":"Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells","volume":"82","author":"Badr","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0760","doi-asserted-by":"crossref","first-page":"10429","DOI":"10.1128\/JVI.01094-10","article-title":"Comparison of immune restoration in early vs. late alpha interferon therapy against hepatitis C virus","volume":"84","author":"Abdel-Hakeem","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.06.035_b0765","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1136\/gutjnl-2011-300515","article-title":"Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection","volume":"61","author":"Missale","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.06.035_b0770","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1053\/j.gastro.2012.10.047","article-title":"Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo","volume":"144","author":"Seigel","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhep.2014.06.035_b0790","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.06.035_b0775","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic silencing of MicroRNA-122 in primates with chronic hepatitis C virus infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.06.035_b0780","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1126\/science.1237568","article-title":"Immunology. An interferon paradox","volume":"340","author":"Odorizzi","year":"2013","journal-title":"Science"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814004656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T15:56:56Z","timestamp":1689609416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814004656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":156,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0168827814004656"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.06.035","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innate and adaptive immune responses in HCV infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}